Eagle Pharmaceuticals, Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows, 14 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-02-18: Reporting owner SCHREIBER ALAIN; Form 4; Security Series C Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2014-02-18: Reporting owner SCHREIBER ALAIN; Form 4; Security Series C Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2014-02-18: Reporting owner Moorin Jay; Form 4; Security Series C Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2014-02-18: Reporting owner Moorin Jay; Form 4; Security Series C Warrants; Transaction X Exercise of in-the-money or at-the-money derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-02-18 | SCHREIBER ALAIN Director, 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Investments IV, L.P. | X Exercise of in-the-money or at-the-money derivative security | −98,368 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | SCHREIBER ALAIN Director, 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Management LLC Plans | X Exercise of in-the-money or at-the-money derivative security | −1,614 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Moorin Jay Director, 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Investments IV, L.P. | X Exercise of in-the-money or at-the-money derivative security | −98,368 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Moorin Jay Director, 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Management LLC Plans | X Exercise of in-the-money or at-the-money derivative security | −1,614 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | ProQuest Investments IV, L.P. | ProQuest Associates IV LLC | ProQuest Management LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Investments IV, L.P. | X Exercise of in-the-money or at-the-money derivative security | −98,368 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | ProQuest Investments IV, L.P. | ProQuest Associates IV LLC | ProQuest Management LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series C Warrants Derivative · Indirect · By ProQuest Management LLC Plans | X Exercise of in-the-money or at-the-money derivative security | −1,614 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-18 | Tarriff Scott Director, Officer (President and CEO) | 4 | Series C Warrant Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −3,438 0 owned after | no price filed | 2014-02-20 | |
| 2014-02-11 holding as of filing | ProQuest Management LLC | ProQuest Associates IV LLC | ProQuest Investments IV, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series C Warrants Derivative · Indirect · By ProQuest Investments IV, L.P. | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | ProQuest Management LLC | ProQuest Associates IV LLC | ProQuest Investments IV, L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series C Warrants Derivative · Indirect · By ProQuest Management LLC Plans | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | SCHREIBER ALAIN Director, 10% Owner | 3 | Series C Warrants Derivative · Indirect · By ProQuest Investments IV, L.P. | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | SCHREIBER ALAIN Director, 10% Owner | 3 | Series C Warrants Derivative · Indirect · By Project Management LLC Plans | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Tarriff Scott Director, Officer (President and CEO) | 3 | Series C Warrant Derivative · Direct | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Moorin Jay Director, 10% Owner | 3 | Series C Warrants Derivative · Indirect · (m) | Holding | $11.67 exercise price | 2014-02-11 | ||
| 2014-02-11 holding as of filing | Moorin Jay Director, 10% Owner | 3 | Series C Warrants Derivative · Indirect · (m) | Holding | $11.67 exercise price | 2014-02-11 |